2008³â Çѱ¹¿¡ ³ë¹ÙƼ½º º¥Ã³Æݵ带 ÅëÇØ ÅõÀÚÇÑ ¹Ù ÀÖ´Â ±Û·Î¹ú Á¦¾à»ç ³ë¹ÙƼ½º°¡ ¶Ç ´Ù½Ã ±¹³» ÅõÀÚó ¹°»ö¿¡ ³ª¼¹´Ù.
18ÀÏ ¼¿ï ±×·£µå ÇϾæƮȣÅÚ¿¡¼´Â KOTRA, Çѱ¹º¸°Ç»ê¾÷ÁøÈï¿ø, ¹ý¹«¹ýÀÎ ÃæÁ¤, Çѱ¹³ë¹ÙƼ½º°¡ ‘¹ÙÀÌ¿À±â¼ú ±Û·Î¹ú»ç¾÷È ÇÁ·ÎÁ§Æ® (GATE II) ¾÷¹« Çù¾à½Ä’À» ü°áÇÏ°í ³ë¹ÙƼ½ºÀÇ ÅõÀÚó ¹°»öÀ» Áö¿øÇϱâ·Î Çß´Ù.
À̳¯ Çù¾à½Ä¿¡´Â KOTRA Á¶È¯ÀÍ »çÀå, Çѱ¹º¸°Ç»ê¾÷ÁøÈï¿ø Àå°æ¿ø ±Û·Î¹úÇコ»ç¾÷¼¾ÅÍÀå, ¹ý¹«¹ýÀÎ ÃæÁ¤ ¸ñ±Ù¼ö ´ëÇ¥, Çѱ¹³ë¹ÙƼ½º ÇÇÅÍ ¾ß°Å(Peter Jager) ´ëÇ¥°¡ Âü¼®Çß´Ù.
»çÁø¼³¸í (¿ÞÂʺÎÅÍ) KHIDI ±èÁø¼ö ±âȹÀÌ»ç, KOTRA Á¶È¯ÀÍ »çÀå, Novartis KOREA Peter Jager ´ëÇ¥ÀÌ»ç, ÃæÁ¤ ¸ñ±Ù¼ö ´ëÇ¥º¯È£»ç°¡ ¹ÙÀÌ¿À±â¼ú ±Û·Î¹ú»ç¾÷È ÇÁ·ÎÁ§Æ® ¾÷¹« Çù¾à½Ä ÈÄ ±â³äÃÔ¿µÀ» ÇÏ°í ÀÖ´Ù.